NorthWest Biotherapeutics Inc (NWBO)

[Evaluate]

For some reason, all these NWBO trials involve enrollment estimates that are multiples of a dozen:

Phase III:
240= 20 dozen
72 = 6 dozen
312 = 26 dozen
348 = 29 dozen

Phase I: 3 dozen
Phase II: 2 dozen ... per cancer type

see Pyrr post 7398 regarding Linda Powers' Presentation (3/27/14):

Then, if seeing efficacy, we go seamlessly into ph II (without needing further approval), where two dozen patients per cancer shall be treated.” --- Pyrr, quoting LP

So perhaps Phase II will be 3 cancer types at 4 dozen each (instead of 6 cancer types at 2 dozen each)?